Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers-Reference-Cited by-同舟云学术

Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers

Published:2006 Issue:1 Volume:16 Page:55-64
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidem. Drug Safe.

Author:

Raebel Marsha A.,McClure David L.,Simon Steven R.,Chan K. Arnold,Feldstein Adrianne,Andrade Susan E.,Lafata Jennifer Elston,Roblin Douglas,Davis Robert L.,Gunter Margaret J.,Platt Richard

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference43 articles.

1. Guidelines for the Evaluation and Management of Heart Failure

2. The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial Infarction

3. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approaches

4. Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potassium: A Frontier in Osteoporosis;Hormone and Metabolic Research;2024-02-12

2. The Incidence of Hyperkalemia in Patients with Shpt after Ultrasound-Guided Radiofrequency Ablation vs Parathyroidectomy;2024

3. Pathophysiology and clinical management of hyperkalemia in chronic kidney disease;Minerva Medica;2023-11

4. Adverse Events After Initiating Angiotensin-Converting Enzyme Inhibitor/Angiotensin II Receptor Blocker Therapy in Individuals with Heart Failure and Multimorbidity;The American Journal of Medicine;2022-12

5. Pragmatic diagnostic and therapeutic algorithms to optimize new potassium binder use in cardiorenal disease;Pharmacological Research;2022-08